You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 296 No. 13, October 4, 2006 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on ISI (2)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Drug Therapy, Other
 •Viral Infections
 •Alert me on articles by topic

Shift Shown in Influenza A Adamantane Resistance

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Dr Bright and colleagues1 reported an increase in adamantane-resistant influenza A viruses in the United States: less than 2% before 2002, 14.5% from October 2004 through March 2005, and 92.3% from October 1 to December 31, 2005. The authors commented that exposure to amantadine and rimantadine did not seem to explain the increased resistance, because only a minority of the samples was from nursing home settings in which the medications are most likely used. However, the viral resistance may be associated with the recent wide-scale use of another adamantane compound, memantine.

Memantine is a derivative of amantadine with 2 methyl side groups that increase its affinity and dwell time in the N-methyl-D-aspartate–sensitive glutamate receptor channel.2 In late 2003, memantine was approved by the US Food and Drug Administration for the treatment of symptoms in moderate to severe Alzheimer disease. After being launched in the . . . [Full Text of this Article]

Raj C. Shah, MD
raj_c_shah@rush.edu
Department of Family Medicine
Rush University Medical Center
Chicago, Ill


RELATED ARTICLES

Shift Shown in Influenza A Adamantane Resistance
Katherine M. Shea
JAMA. 2006;296(13):1585.
EXTRACT | FULL TEXT  

Shift Shown in Influenza A Adamantane Resistance—Reply
David K. Shay, Rick A. Bright, Michael Shaw, Nancy J. Cox, and Alexander I. Klimov
JAMA. 2006;296(13):1586-1587.
EXTRACT | FULL TEXT  

Shift Shown in Influenza A Adamantane Resistance—Reply
David M. Weinstock and Gianna Zucotti
JAMA. 2006;296(13):1587.
EXTRACT | FULL TEXT  

Adamantane Resistance Among Influenza A Viruses Isolated Early During the 2005-2006 Influenza Season in the United States
Rick A. Bright, David K. Shay, Bo Shu, Nancy J. Cox, and Alexander I. Klimov
JAMA. 2006;295(8):891-894.
ABSTRACT | FULL TEXT  

Adamantane Resistance in Influenza A
David M. Weinstock and Gianna Zuccotti
JAMA. 2006;295(8):934-936.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.